Cargando…
Metformin, Rapamycin, or Nicotinamide Mononucleotide Pretreatment Attenuate Cognitive Impairment After Cerebral Hypoperfusion by Inhibiting Microglial Phagocytosis
Vascular cognitive impairment (VCI) is the second leading form of dementia after Alzheimer's disease (AD) plaguing the elder population. Despite the enormous prevalence of VCI, the biological basis of this disease has been much less well-studied than that of AD, with no specific therapy current...
Autores principales: | Yu, Mengdi, Zheng, Xiaoying, Cheng, Fangyu, Shao, Bei, Zhuge, Qichuan, Jin, Kunlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234123/ https://www.ncbi.nlm.nih.gov/pubmed/35769369 http://dx.doi.org/10.3389/fneur.2022.903565 |
Ejemplares similares
-
Nicotinamide Improves Cognitive Function in Mice With Chronic Cerebral Hypoperfusion
por: Liu, Bin, et al.
Publicado: (2021) -
Antioxidant effect of nicotinamide mononucleotide in tendinopathy
por: Yamaura, Kohei, et al.
Publicado: (2022) -
Identification of the nicotinamide mononucleotide adenylyltransferase of
Trypanosoma cruzi
por: Niño, Carlos H, et al.
Publicado: (2015) -
Correction: Antioxidant effect of nicotinamide mononucleotide in tendinopathy
por: Yamaura, Kohei, et al.
Publicado: (2022) -
Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
por: Hara, Nobumasa, et al.
Publicado: (2011)